Clinical Trial

A Clinical Study to Evaluate the Efficacy, Tolerability, and Safety of Bempedoic Acid

Recruiting Phase 3
View on ClinicalTrials.gov →
Record status
This record was last updated January 17, 2025 (before its estimated October 2025 completion). Its status may not reflect the trial's current state.
Summary
This trial is a phase III study to evaluate the efficacy , tolerability, and safety of Bempedoic Acid Tablets in patients with hyperlipidemia not adequately controlled by Statins.
Trial Details
NCT Number NCT06780410
Lead Sponsor Gan & Lee Pharmaceuticals.
Conditions Primary Hyperlipidemia
Enrollment 240 participants
Start Date 2024-12-20
Primary Completion 2025-10 (estimated)
Study Completion 2025-10 (estimated)
Updated on ClinicalTrials.gov 2025-01-17